Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer

Yaqin Tu, Cai Chen, Guorun Fan
2019 BMC Cancer  
While many studies have assessed the predictive value of secreted phosphoprotein (SPP) genes in cancer, the findings have been inconsistent. To resolve these inconsistencies, we systematically analyzed the available data to determine whether SPP1 and SPP2 are prognostic markers in the context of human cancer. The expression of SPP1 and SPP2 was assessed by Oncomine analysis. The PrognoScan database was used to assess the prognostic value of SPP1 and SPP2, with cBioPortal used to assess copy
more » ... er variations. The STRING database was used to generate a Protein - Protein Interaction (PPI) network for SPP genes. SPP1 was more likely to be over-expressed in breast, bladder, colorectal, head, neck, liver, lung, and esophageal cancers. SPP2 was expressed at lower levels in colorectal cancer, leukemia, liver cancer and pancreatic cancer. In addition, SPP1 and SPP2 mutations mainly occurred in cutaneous melanoma and endometrial cancer. Our results suggest that SPP1 and SPP2 may be effective therapeutic or diagnostic targets in certain cancers. Further research is required to confirm these results and verify the value of SPP1 and SPP2 as clinical markers of cancer prognosis.
doi:10.1186/s12885-019-6441-3 pmid:31849319 pmcid:PMC6918603 fatcat:m4f25ef5ubg6vbvos2hzkogxiu